Your shopping cart is currently empty

Anticanceragent 241 (HZ1) is a novel orally active inhibitor specifically targeting cell cycle-dependent kinase-like 3 (CDKL3). It demonstrates potent antitumor effects and has the potential to overcome resistance to CDK4/6 inhibitors.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 4-6 weeks | 4-6 weeks | |
| 50 mg | $1,980 | 4-6 weeks | 4-6 weeks | |
| 100 mg | $2,500 | 4-6 weeks | 4-6 weeks |
| Description | Anticanceragent 241 (HZ1) is a novel orally active inhibitor specifically targeting cell cycle-dependent kinase-like 3 (CDKL3). It demonstrates potent antitumor effects and has the potential to overcome resistance to CDK4/6 inhibitors. |
| In vitro | Anticancer agent 241 (HZ1; 100 nM) notably diminishes the levels of pRb and CDK4, effectively inducing cell cycle arrest and tumor cell death. |
| In vivo | Anticancer agent 241 (HZ1; 1 mg/kg; oral gavage; daily for 12-14 days) exhibits anticancer activity in a mouse colon cancer model. |
| Molecular Weight | 362.43 |
| Formula | C20H22N6O |
| Cas No. | 3030492-40-8 |
| Smiles | O=C(C1=CC=C(C=C1)NC2=NC=CC(=N2)NC3=CC(=NN3)C4CCCC4)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.